30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator?

Jacobus Adrianus Burgers, Ronald Alphons Damhuis

Source: ERJ Open Res, 4 (4) 00030-2018; 10.1183/23120541.00030-2018
Journal Issue: October
Disease area: Thoracic oncology

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jacobus Adrianus Burgers, Ronald Alphons Damhuis. 30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator?. ERJ Open Res, 4 (4) 00030-2018; 10.1183/23120541.00030-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: